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Abstract Thrombospondin 1 is present in articular cartilage and 
is synthesized by chondrocytes. Adult bovine articular chondro- 
cytes in serum-free medium were evaluated in a solid-phase assay 
for their ability to attach to thrombospondin 1 isolated from 
human platelets. The chondrocytes attached to the throm- 
bospondiu 1 by a mechanism that was inhibited by a synthetic 
linear GRGDSP but not a GRGESP peptide. The cells, however, 
did not spread on thrombospondiu 1, but did spread on fibrouectin 
and Pep-Tite 2000, a synthetic RGD-containing peptide. Pre- 
incubation of thrombospondin 1 with EDTA irreversibly inhibited 
its capacity to attach to chondrocytes. We conclude that throm- 
bospondin 1 binds to chondrocytes by its RGD sequence. 
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1. Introduction 
Chondrocytes in articular cartilage are surrounded by an 
abundant extracellular matrix consisting of collagens, pro- 
teoglycans and matrix proteins [1,2]. The cell surface and imme- 
diate pericellular environment of the condrocyte have critical 
roles in tethering the cells to their extracellular environment 
and in signal transduction processes. The pericellular matrix of 
mature articular cartilage, when viewed in the electron micro- 
scope, is clearly distinguishable from the dense fibrillar mesh- 
work of the inter-territorial matrix [3]. Proteins that are present 
in cartilage and can attach to cells are good candidates for 
participation i these cell-pericellular matrix interactions. In a 
previous report we demonstrated that thrombospondin 1, a 
protein containing the amino acid sequence RGD, is present in 
articular cartilage and is synthesized by chondrocytes [4]. 
Thrombospondin 1 can now be categorized with type VI 
collagen and fibronectin as a member of the multidomain fam- 
ily of connecting, or adhesive proteins that bind to cells and 
other matrix molecules and play critical roles in organizing 
pericellular and extracellular matrices [5]. Thrombospondin 1 
is a trimeric glycoprotein consisting of three identical monomer 
chains [6]. It was first identified as a component of platelet 
alpha granules [7]. Besides cartilage, thrombospondin 1 ispres- 
ent in meniscus, ligament, and intervertebral disc [8], as well as 
other connective tissues [9]. The RGD sequence in a variety of 
adhesive proteins often mediates their interaction with specific 
members of the integrin family of receptors [10]. Although 
thrombospondin 1 promotes cell attachment in both normal 
and transformed cells [11,12], some of these interactions are not 
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inhibited by the RGD-containing peptide [13], suggesting that 
more than one mechanism exists in the protein for cell attach- 
ment to thrombospondin 1. 
Thrombospondin 1 appears to play a role in wound healing 
and various pathological processes. In traumatized skeletal 
muscle, the temporal appearance of thrombospondin 1 iscorre- 
lated with post-trauma generation [14]. Thrombospondin 1 has 
also been suggested to play a role in the early organization of
the extracellular matrix of human skin [15] and corneal [16] 
wounds. In atherosclerotic lesions, thrombospondin 1 staining 
was especially prominent [9]. In a related study, interleukin-1, 
a cytokine believed to play a role in bone and cartilage destruc- 
tion, specifically stimulates the expression of thrombospondin 
in rabbit articular chondrocytes while having no effect on fi- 
bronectin [17]. 
The capacity of chondrocytes to attach to thrombospondin 
1 has not been investigated. We here report that chondrocytes 
isolated from adult bovine articular cartilage bind to, but do 
not spread, on thrombospondin 1 by an RGD-dependent 
mechanism, and that a divalent cation, presumably calcium, in 
the structure of thrombospondin 1 is essential for the interac- 
tion. 
2. Experimental 
2.1. Materials 
Gelatin-agarose and 3-(4,5-dimethylthiazol-2-yl)-2,5-dyphenyl tetra- 
zolium bromide (MTT) were obtained from Sigma (St. Louis, MO). 
Heparin-Sepharose was purchased from Pharmacia (Uppsala, Swe- 
den). Medium and cell culture reagents were obtained from Gibco 
(Grand Island, NY). Fetal bovine serum was purchased from Cell 
Culture Laboratories (Cleveland, OH). Pep-Tite 2000 was obtained 
from Telios Pharmaceuticals (San Diego, CA). Bio-Gel A 0.5 m was 
purchased from Bio-Rad (Richmond, CA). Outdated human platelets 
were obtained from the American Red Cross (Cleveland, OH). Mono- 
clonal antibody against human platelet hrombospondin was kindly 
provided by Dr. Deane F. Mosher (University of Wisconsin, Madison, 
WI). 
2.2. Preparation of thrombospondin 1 
Thrombospondin 1 was purified from human platelets essentially as
described by [4]. Outdated human platelets were centrifuged at180 × g~v 
for 15 rain at room temperature to remove remaining blood cells. The 
supernatant was removed and 1/5 vol. of ACD (citric acid, 8 gm/1; 
sodium citrate, 22 gin/l; and glucose, 24.5 gm/1, pH 4.5) was added. The 
platelets were centrifuged at1100 x gay for 10 min and resuspended in 
0.15 M NaCI, 4.3 mM K2HPO4, 4.3 mM Na2PO4, 24 mM NaHPO4, 
5 mM glucose, pH 6.5. The platelets were washed twice by resuspending 
and centrifuging in the above buffer. The final pellet was resuspended 
in 0.15 M NaCI, 20 mM Tris-HC1, pH 7.5, 0.1 mM CaC12, 5 mM 
glucose. This suspension was warmed to 37°C, and thrombospondin 
1 secretion i duced by the addition of human thrombin (0.5 U/ml) for 
2 min until arge aggregates formed. After the addition of phenylmeth- 
ylsulfonyl f uoride to inhibit he thrombin, the platelet aggregates were 
removed by centrifugation for 5 min at 200 × gay at 4°C. The superna- 
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tant was then centrifuged at 20,000 × g~v. The final supernatant was 
removed and made 1 mM in CaC12 by adding an appropriate volume 
from a stock of 1 M CaCI2 solution. 
The solution was applied to a gelatin-agarose column (1 ml/10 U of 
platelets) equilibrated in affinity column buffer (20 mM Tris-HCl, pH 
7.5, 0.15 M NaCI, 0.1 mM CaCI2) to remove fibronectin. The column 
was washed with 5 column vols. of buffer. The unbound material was 
applied directly to a heparin-Sepharose column (1 ml/2 U of platelets) 
equilibrated in the affinity column buffer. The material bound to the 
heparin-Sepharose was eluted with a stepwise gradient consisting of 
column buffer containing 0.25, 0.60, and 2.0 M NaCI. The majority of 
the thrombospondin 1 eluted in the 0.60 M fraction as assessed by an 
ELISA using a monoclonal antibody against human thrombospondin 
1. The purified thrombospondin 1 migrated as a single band on SDS- 
PAGE at a molecular weight of 180 kDa and as a single band on a 
Western blot probed with the antibody [4]. This fraction was used for 
the attachment s udies described below. 
2.3. Chondrocyte culture 
Chondrocytes were isolated essentially according to the method of 
Green [18]. Articular cartilage from an adult bovine ankle joint was 
dissected carefully to remove any adhering tissue. The dissected tissue 
was weighed and then incubated with testicular hyaluronidase (5 mg/g 
of tissue) in Hank's balanced salts solution (HBSS) for 15 rain at 37°C. 
The tissue was washed with HBSS and subsequently digested with 
trypsin and collagenase (0.2% each in HBSS) for 1 h at 37°C followed 
by an overnight digestion with 0.2% collagenase. The cells were filtered 
through a 153 pm nylon sieve (Tetko, Elmsford, NY) and then washed 
twice by centrifugation atlow speed (1000 × gay) in HBBS. The final cell 
pellet was resuspended, counted with a hemocytometer and plated at 
a density of 2 × 106 cells per 100 mm dish in Dulbecco's modified 
Eagle's medium (DMEM) supplemented with 10% fetal bovine serum 
(FBS), penicillin (100 U/ml), streptomycin (100/2g/ml) and amphoter- 
icin-B (0.25/2g/ml). Cultures were incubated at 37°C in an atmosphere 
of 10% CO2 in a humidified incubator. 
2.4. Coating of microwell plates 
Thrombospondin 1 and bovine serum albumin (BSA) were diluted 
to a final concentration of 20/2g/ml in HBSS. Pep-Tire (a synthetic 
RGD containing peptide) was diluted to a final concentration of 5 
pg/ml in HBSS. Protein or peptide solutions (100/21) were adsorbed 
onto Falcon microwell dishes overnight at 4°C. The next day the wells 
were washed three times with 100/21 of HBSS to remove any unad- 
sorbed protein. 
2.5. Attachment assay 
Articular cartilage chondrocyte attachment was measured as previ- 
ously described [19]. Briefly, chondrocytes were added to coated mi- 
crowells at a density of 50,000 cells per microwell. After a 2 h attach- 
ment period, the wells were washed three times with HBSS to remove 
any unattached cells. MTT in serum-free DMEM without he Phenol 
red indicator (100/21) was added to each well and incubated for 3 h at 
37°C. The dye-containing medium was then aspirated and 100/21 of 
propanol was added to each well. The plates were vigorously shaken 
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Fig. 1. Concentration dependence ofchondrocyte attachment to throm- 
bospondin 1. Microwells were coated with 0-20 /2g/ml of throm- 
bospondin 1and attachment was assayed as described in section 2. 
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Fig. 2. Effect of synthetic peptides on the attachment of chondrocytes 
to thrombospondin 1. Microwells were coated with 20/2g/ml of throm- 
bospondin 1in the presence or absence of peptides (1 mM) and attach- 
ment was assayed as described in section 2. 
to solubilize the bound formazan, and the optical density of each well 
was measured in a Bio-Rad EIA reader at a wavelength of 550 nm. 
3. Results 
3.1. Cell attachment to thrombospondin 1 
Chondrocytes isolated from bovine articular cartilage at- 
tached to thrombospondin  1-coated microwells (Fig. 1). The 
attachment of the chondrocytes to thrombospondin  1 was con- 
centration dependent and saturable. As a negative control, BSA 
did not promote attachment at coating concentrat ions up to 
1 mg/ml (data not shown). While chondrocytes attached to 
microwells coated with thrombospondin  1, almost all of the 
cells failed to spread in a 2 h incubation (data not shown). In 
contrast, more than 85% of the chondrocytes attached to wells 
coated with fibronectin or Pep-Tite 2000 spread in 2 h. In other 
studies, the vast majority of chondrocytes were attached and 
spread after 2 h on wells coated with type VI collagen or 
f ibronectin [20]. 
3.2. Effect of  synthetic peptides on chondrocyte attachment 
The role of the cell binding RGD sequence of throm- 
bospondin 1 in chondrocyte attachment was examined by add- 
ing the synthetic peptides GRGDSP and GRGESP in the at- 
tachment assay as potential competitive inhibitors. As seen in 
Fig. 2, at a concentrat ion of 1 mM,  the GRGDSP peptide 
completely inhibited chondrocyte attachment. In contrast, the 
GRGESP peptide had no effect when added at the same con- 
centration. 
3.3. Effect of EDTA pretreatment of thrombospondin 1 on 
chondrocyte attachment 
The structure of thrornbospondin 1 is sensitive to the pres- 
ence of calcium [21]. Removal  of calcium from throm- 
bospondin 1 causes an irreversible change in the molecule. The 
importance of this calcium sensitivity of thrombospondin  1 on 
the attachment of chondrocytes was examined by adsorbing 
thrombospondin  1 to microwells in the presence of 2.5 mM 
EDTA. The wells were washed to remove the EDTA and at- 
tachment then measured. As shown in Fig. 3, this pre-treatment 
of the thrombospondin  1 with EDTA completely abolished 
attachment. When calcium was added to the EDTA-treated 
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Fig. 3. Effect of pretreatment wi h EDTA on the attachment ofchon- 
drocytes to thrombospondin 1. Microwells were coated with 20 ,ug/ml 
of thrombospondin 1 either in the presence or absence of EDTA (2.5 
raM) and attachment was assayed as described in section 2. 
thrombospondin l, the ability to attach chondrocytes was not 
restored (data not shown). This observation is probably not due 
to a reduced ability of calcium-depleted thrombospondin l to 
bind to plastic since Lawler et al. [21] observed equivalent 
binding of radiolabeled thrombospondin 1 to plastic in the 
presence or absence of calcium. The failure of the exogenous 
calcium to restore attachment activity to the EDTA-treated 
chondrocytes i also consistent with previous observations 
mentioned above. These observations clearly emphasize the 
importance of not exposing thrombospondin 1 to metal chela- 
tors during purification. 
4. Discussion 
We have demonstrated the ability of thrombospondin 1 iso- 
lated from human platelets to mediate the attachment of chon- 
drocytes from adult bovine articular cartilage in a solid-phase 
assay. The attachment of chondrocytes to thrombospondin 1 
was inhibited by the linear peptide GRGDSP, demonstrating 
the requirement for the RGD sequence of thrombospondin 1 
in this attachment. In this respect the mechanism of attachment 
of thrombospondin 1 to chondrocytes was similar to that of 
fibronectin, but differed to that of type VI collagen, another 
RGD-containing protein [20]. Attachment also depended upon 
the presence of calcium, since removal of calcium from throm- 
bospondin 1by treatment with EDTA completely inhibited the 
subsequent attachment of chondroeytes. A recent study [22] 
reported that bovine cartilage oligomeric protein (COMP) at- 
tached to articular cartilage chondrocytes, but that throm- 
bospondin 1 did not. However, it should be noted that the 
thrombospondin 1 in that study was exposed to EDTA during 
its isolation, a procedure that irreversibly abolishes its capacity 
to attach chondrocytes. 
Thrombospondin 1 can now be added to a growing list of 
matrix molecules that can bind to chondrocytes. Other mem- 
bers of this group include type V1 collagen and fibronectin [20] 
and a range of matrix proteins [23]. However, unlike most other 
members of this group, thrombospondin 1 does not appear to 
cause chondrocytes to spread, at least under the conditions 
employed in our study. This observation supports those of 
Murphy-Ullrich and H66k [24] in which they showed that 
thrombospondin 1 destabilizes cell adhesion by preventing 
focal adhesion formation and by loss of preformed focal adhe- 
sions. They suggested that thrombospondin 1 may function by 
priming cells for mitosis by inhibiting the formation of focal 
adhesion plaques. This is supported by findings that throm- 
bospondin 1is involved in the mechanisms of cellular prolifer- 
ation [12,25]. The functions of thrombospondin 1 in normal 
and pathological rticular and meniscal cartilage remain to be 
established. 
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